ALX Oncology clinical trials we track

Check company identity source

Phase 2 / 3 1 trial

Phase 2 3 trials

Drugs in these trials

Names as written in the registry records.

Latest recorded trial changes

Filters
Clear filters

· 4 fields changed

Main study measure wording changed

Text changed; whether the study measures changed has not been verified. Saved text may be shortened.

Before: Measure: MBC substudy: Overall Response Rate (ORR) using RECIST v1.1 based on BICR assessment. After: Measure: Overall Response Rate (ORR) using RECIST v1.1 based on BICR assessment.

Planned enrollment increased by 40 participants

Before: 80 participants (planned). After: 120 participants (planned).

Primary completion date changed

Before: Jun 2027. After: Dec 2027.

Phase changed

Before: PHASE1, PHASE2. After: PHASE2.

Check registry source